Summary. The contributions of polygenic loci and environmental factors to femoral bone mineral density (BMD in g/cm z) variability were estimated in modified family sets consisting of women of child-bearing age. Femoral BMDs were measured in 535 women who were members of 137 family sets consisting minimally of an index, her sister, and unrelated female control. The family set could also include multiple sisters and first cousins. Women included in these family sets were all between 20 and 40 years of age to minimize the cohort effects of maturation and menopause on measures of BMD. BMDs were measured at three femoral sites using dual photon densitometry. Values were regressed on age and Quetelet Index which explained 13-15% of the variability in BMD (dependent on site). Subsequent variance components analysis on the residuals indicated that unmeasured polygenic loci accounted for substantial additional variability: 67% for femoral neck, 58% for Wards triangle, and 45% for trochanter. These results suggest that polygenic loci account for approximately half of the variability in maximal femoral BMD.
Genetic -Epidemiologic methods.
bone loss may be influenced by genetic factors associated with the level of hormones, perimenopausally, as well as by the environmental influences of exposure to exogenous estrogen.
Estimates of heritability may also vary according to particular bone site, potentially because of the nature of the interaction of genetic and environmental influences. For example, Dequeker et al. [12] reported a heritability estimate of 0.75 for the distal radius among 13 pairs of monozygotic and dizygotic twins (greater than 25 years of age) whereas the estimate of heritability at the spine among the same twin pairs was -0.57. Though hip fracture has substantially greater social, economic, and mortal outcomes than fracture of spine or wrist, relatively few studies have reported a genetic component for BMD of the femur [3] , suggesting the need to determine consistency of heritability at multiple bone sites.
The purpose of this study was to estimate for peak femoral bone mass the proportion of variability explained by genetic and environmental factors in a sample of 535 healthy women, aged 20-40 years. The results provide insight into the contribution made by familial factors to the variability of peak femoral BMD.
Study of factors associated with bone mineral density (BMD in g/cm 2) is important to establish profiles of individuals who are at risk for osteoporosis and fracture [1] . Osteoporosis is thought to be multifactorial in its etiology, involving both heredity and environmental contributions [2, 3] .
Increasingly, researchers hypothesize that a primary determinant of risk for osteoporosis may be the amount of skeletal bone mass acquired in adolescence and early adulthood [4] , which is referred to as "peak" or "maximal" bone mass. A lower peak bone mass, premenopausally, when combined with a substantial bone loss, perimenopausally, may place women at a higher risk of osteoporosis. Frequently, the genetic contribution to osteoporosis has been based on the study of bone in aged individuals [5, 6] , mixed generation groups [7] [8] [9] [10] , and mixed gender groups [5, 11] . However, in women the protracted events of menopause and associated estrogen replacement may obscure the nature and strength of the genetic contribution. Furthermore, maximal BMD in early adulthood may have different genetic determinants than postmenopausal osteoporosis. Postmenopausal Offprint requests to: MaryFran R. Sowers
Materials and Methods

Source Population
This study was designed to describe characteristics of maximal bone mass, including its familiality, in adult women, ages 20--40 years. A modified family set method was used to identify related and nonrelated participants for study of characteristics that might be familial. To that end, we recruited groups that consisted minimally of an index woman, her sister, and a nonrelated friend control identified by the index, within the specified age range. Female, age-eligible first cousins and all age-eligible sisters of the index were asked to participate, if available. As ascertainment was independent of femoral bone mass, assignment as an index case among sisters was random and based only on which sister was located by telephone first.
Participants were associated with Tecumseh, Michigan, a rural community (n -10,000) and its immediate environs which have served as the location for the Tecumseh Community Health Study (TCHS), a total-community study of chronic diseases. Families with age-eligible female siblings were identified from the TCHS baseline family member roster. Additional participants were recruited by presenting the study to organizations and employers with substantial female membership, and advertising in the local newspaper.
Women were excluded from data collection if they were not 20-40 years, were pregnant or thought they might be pregnant, or were cognitively unable to provide informed consent. Women who identified their ethnic origin as non-Caucasian were eliminated from data analyses because of small numbers. A total sample of 535 women in 137 family sets contributed BMD information. There were one hundred forty-five unrelated controls, 60 cousins, and 137 sibships distributed as 96 sibships with 2 sisters, 31 sibships with 3 sisters, 7 sibships with 4 sisters, 2 sibships with 5 sisters, and 1 sibship with 7 sisters. Our participation rate was 81% of women contacted who lived within 25 miles of Tecumseh. All activities were undertaken according to guidelines of the University of Michigan Institutional Review Board. Women were contacted by an interviewer to describe the study protocol and to secure consent to participate. A clinic visit was scheduled and a self-administered health questionnaire was provided. The clinic visit included an additional interview about lifestyle, diet, reproductive history, and health history. BMDs (bone mineral content/bone area) of the femoral neck, Wards triangle, and trochanter were measured using a Lunar DP3 TM dual photon densitometer (Madison, WI) fitted with a Gd 153 source. The location of these specific sites has been previously described [13] . The coefficient of variation from repeated measures, a measure of precision, was 3%. The source was replaced immediately prior to the beginning of this study and was not replaced during the 9-month period of data collection. Calibration was undertaken before each clinic visit; generally, 6--8 women were measured during each clinic visit. A single technician conducted all measurements. The hip was selected for measurement because fracture at this site has substantially greater social, economic, and mortal outcomes than fracture of the spine or wrist [14] . Measurement of BMD has been reported to be predictive of hip fracture incidence and also reflects spinal osteopenia [15, 16] .
Measurements
The clinical assessment included measurement of height and weight. Height was measured to the nearest millimeter using a height board; weight was measured in quarter pounds using a standardized balance-beam scale. These values were used to calculate a Quetelet Index (weight/height 2) which is weight adjusted for height.
Variables and Statistical Analyses
All variables were assessed for the normality of the distribution, and descriptive statistics were calculated. Prior to analyses to characterize potential genetic or familial associations, we examined factors that might influence BMD. This examination used only data from the 282 women who were neither related by blood nor residence in the same household. Factors examined included current and historic calcium intake, smoking practices, alcohol use, reproductive characteristics (i.e., parity, age of menarche, oral contraceptive use), and age and measures of body size. Age and Quetelet Index were significantly associated with femoral BMD, explaining between 15 and 19% of the variability in these unrelated participants, depending on the site [17] . BMD values were regressed on age and Quetelet Index; residual values were used in the analysis of variance and variance components analysis.
One-way analysis of variance was used to assess familiality of BMD variability [18] . Familiality describes the influence of family membership on a phenotypic characteristic, but does not reflect whether phenotypic expression is due to genetic factors, common living environment, or both.
Variance components analysis was used to estimate the proportion of variability of femoral BMD due to unmeasured genetic and environmental factors. Residuals from the regression analysis were analyzed under the polygenic model [19] . The model assumed that adjusted femoral BMD represented the summed effects of additive genes, unmeasured factors shared by members within the same family set, and unmeasured factors specific to each individual (including measurement error) to provide a mechanism other than shared genes as a possible explanation of the familial aggregation of femoral BMD. We speculated that unmeasured factors shared by members within the same family might include such things as eating patterns, frequency of pregnancy and lactation, and even medical careseeking.
Following Lange et al. [20, 21] , we assumed that after adjustment for age and Quetelet Index, the femoral BMD measurements for a family set followed a multivariate normal distribution. Theoretic justification of the assumption of multivariate normality has been given elsewhere [21, 22] . Under these assumptions, we partitioned the total within-in individual phenotypic variability 0-2 of adjusted femoral BMD as a sum of variance components 0 -2 = 0-g2 + O'C2 ~-ere 2, where 0-g2 is the additive genetic variance, crc2 is the variance of factors shared by members of the same family set, and ~re 2 is the variance of factors specific to the individual, including measurement error. Under this model, covariances between relatives are 1/2 crg z + O'C 2 for sisters, 1/8o'g 2 + O' C 2 for cousins, and 0-c2 for unrelated members of the same family set. Under the assumption of independent family sets, the loglikelihood of the data set was the sum of the multivariate normal log-likelihoods for the individual family sets. Calculation and maximization of these log-likelihoods was carried out using the computer program FISHER [23] . Maximizing the log-likelihood permitted maximum likelihood parameter estimation; it also provided a means for hypothesis testing of nested models using the likelihood ratio criterion, and for maximum likelihood comparison of nonnested models. We constrained the variance components to be positive because there is no evidence of familial disaggregation in BMD.
Results
The mean and standard deviation of the normally distributed femoral BMDs for the neck, Wards triangle, and trochanter are shown in Table 1 . These values are slightly lower (-3% for femoral neck and Wards triangle; 2% for trochanter) than those reported by Mazess and Barden [24] who used the same instrumentation to characterize women of the same age group. Table 2 describes the physical characteristics of women in the sample including height, weight, Quetelet Index, and age.
A one-way analysis of variance of the unadjusted femoral BMD values suggested highly significant familial aggregation and were as follows: femoral neck (R 2 = 0.65, P < 0.0001); Wards triangle (R 2 = 0.64, P < 0.0001); and trochanter (R z = 0.66, P < 0.0001). The proportion of variation explained by sibships for values, adjusted for age and Quetelet Index, for femoral BMD were as follows: femoral neck (R 2 --0.68, 0.00 *** Parameter bounded at zero P < 0.0001); Wards triangle (R 2 = 0.67, P < 0.0001); and trochanter (R 2 = 0.69, P < 0.0001).
Variance components analysis was used to characterize the summed effects of unmeasured genes and unmeasured environmental factors in addition to that already attributed to body size, expressed as Quetelet Index and age. Residuals from regression analysis of BMD with age and Quetelet Index were used under the assumption that age and Quetelet Index were known concomitants and that adjustment for them allowed for the description of polygenic factors for BMD in excess of body size. Results of the analysis for the age and Quetelet-adjusted femoral BMDs, including the parameter estimates and their standard errors, are shown in Table 3 . The variance shown for Model 1 is segmented into separate components in Models 2, 3, and 4. Model 4 is the complete model reflecting the sum of the variance components for which partitioning was undertaken. The likelihood ratio statistics compare individual component models to the complete model to test the hypothesis of no difference between models.
The estimates shown in Table 3 suggest the presence of a significant genetic effect for all three sites, although shared environment cannot be dismissed as an explanation for trochanter and Wards triangle. At the femoral neck site, the most parsimonious model included genes and the unmeasured component specific to the individual. This model attributed 79% of the variability in regressed BMD, adjusted for age and body size, to genes (79% = 0.00974/(0.00259 + 0.00974)). For Wards triangle, this genetic model attributed 67% of the variability in adjusted BMD to genes. For the trochanter, the complete model attributed 52% of variability to genes and 7% of the variability to an unmeasured factor shared by members of a family set; the genetic model attributed 66% of the variability. Table 4 summarizes the proportion of variability explained by measured concomitants, unmeasured genes, and unmeasured factors shared by members of a family set. At the femoral neck, age and body size, the measured concomitants, accounted for 15% of the variability in BMD, leaving 85% of variability unexplained. Under the variance components analysis, unmeasured genes accounted for an additional 67% (85% x 79%) of the variability. Similarly, in models for the trochanter and Wards triangle, genes accounted for an additional 45% and 58% of variability, respectively. The three proximal femur sites are interrelated such that quantified variability associated with genes is not independent.
Discussion
This partitioning of the variability of peak femoral BMD suggests that substantial variation may be explained by unmeasured genes. Prior to considering familial factors, measured concomitants (age and Quetelet Index) explained 13-15% of the variability. Unmeasured genes and unmeasured environmental factors shared by members of a family set explained an additional 51-67% of the variability in peak femoral BMD, depending on femoral site.
The values reported appear to be consistent with those of Pocock et al. [25] who studied femoral BMD in 32 female and 6 male monozygotic twin pairs, as well as 26 female and 1 male dizygotic twin pairs (aged 24-75 years). The genetic component would have been greater had we not already adjusted for the variability attributable to body size (data not shown), a characteristic previously observed to have a genetic component [26, 27] .
Establishing that genes play a role in determining femoral [5, 6] or mixed generations [7] [8] [9] [10] . The interpretation of a genetic contribution to peak BMD in these studies may have been obscured by the multiple lifestyle factors that influence the estimate of BMD. In women particularly, the protracted onset of menopause and treatment of its symptomatology may obscure important relationships [8] . However, studies of more aged populations may help to establish a role for an additional genetic contribution of menopause to BMD. Previous evaluations of a genetic contribution to osteoporosis have used estimates of bone mineral content from the appendicular skeleton, usually the distal radius, in studies of twins [5, 6, 11, 12] , mother/daughter pairs [8, 9, 28] , and racial differences [29, 30] . However, it is recognized that hip fractures are the predominant events of interest in terms of increased mortality and health care costs [14] . Fractures at the hip may be associated with lifestyle risks different than risks associated with the distal radius. For example, weight bearing is likely to contribute more strongly to the level of femoral BMD and influence the phenotypic expression of the heritable contribution. Thus, it is important to determine the consistency of heritable components at several skeletal sites. Recent studies using parent/offspring correlations [10, 31, 32] and relatives of osteoporotic patients [33] suggest the importance of a genetic role in peak bone density. Because the studies are characterized by small samples of volunteers, confirmation with a larger sample using a community-based sampling frame is important.
Variance components analysis can be helpful in distinguishing whether the familiality of femoral BMD are more likely to have a genetic or environmental component. Even when such a distinction is made, the magnitude may not be definitive. Though the genetic model has a substantially greater likelihood than the shared family set environmental model for the femoral neck, the shared family environment model cannot be dismissed as an explanation for the data at the other two sites. This study suggests that consideration of genetic influence is important. Having established a substantial role for gene(s) in peak femoral bone mass, the next step would be to begin a more systematic study of genetic etiol-113 ogy. For example, no study has identified that healthy women with low peak BMD have a genetic profile different from that of women with average peak BMD; this is an area for future exploration. Additionally, we have shown that low estrogen levels are significantly associated with low premenopausal BMD [34] . It would be important to determine if bone mass heritability is similar in premenopausal women with higher and lower estrogen levels.
